Creation of glucose from sources other than carbs (proteins, glycerol, lactate)
Glycogenesis
Creation of glycogen (easily turned into glucose)
Glycolysis
The breakdown of glucose with an individual cell to release ATP
Glycogenolysis
Breakdown of glycogen to glucose
Diabetes
Abnormality in blood glucose regulation and nutrient storage related to an absolute deficiency in insulin or resistance to actions of insulin
Functions of the pancreas
Exocrine (digestive enzymes and bicarbonate in duodenum)
Endocrine (insulin and glucagon for blood glucose levels)
Cells in the pancreas
F cell (secretes pancreatic polypeptide)
Beta cell (secretes insulin)
Alpha cell (secretes glucagon)
Delta cell (secretes somatostatin)
Insulin
Drives glucose into cell, produced in beta cells, causes uptake of glucose into cells and its storage as glycogen, fat, protein, stimulates glucose breakdown for energy within a cell, promotes storage and breakdown, prevents fat breakdown and glycogen breakdown
Glucagon
Made in alpha cells, stimulates the release of glucose into your blood when fasting, liver is prime storage depot, increases glycogenesis (breakdown of glycogen to glucose)
In starvation
The goal is to protect the brain and the heart, glucagon mobilizes glucose stores from the liver so it can be sent to brain and heart, also increases the transport of amino acids to liver to stimulate gluconeogenesis
Counter Regulatory Hormones
Catecholamine
Growth hormone
Glucocorticoids
Counter Regulatory Hormones counteract storage of insulin to decrease depletion of serum to glucose during fasting, exercise, illness (fever), and stress
Types of Diabetes
Type 1
Type 2
Gestational
Type 1 Diabetes
Loss of production of insulin, autoimmune (Type 1a) or idiopathic (Type 1b)
Type 2 Diabetes
Insulin resistance by body cells, increase in production to compensate for peripheral tissue resistance and mechanism fails, burn out of pancreas
Risk factors for Type 2 Diabetes
Age
Obesity
Family history
Metabolic abnormalities in Type 2 Diabetes
Insulin resistance
Increased glucose production by liver
Deranged secretion of insulin by pancreatic beta cells
Obesity and physical inactivity are the two paramount factors in the development of Type 2 Diabetes
Features of Metabolic Syndrome (Type 2 Diabetes)
Abdominal sensitivity
Hyperglycemia
Hypertension
Hyperlipidemia
Role of Adipose Tissue in Type 2 Diabetes
Increase in free fatty acids, excess free fatty acids cause pancreatic beta cell dysfunction (lipotoxicity), free fatty acids inhibit glucose uptake and glycogen storage, accumulation of free fatty acids decreases insulin sensitivity, leads to increased hepatic glucose production and hyperglycemia
Gestational Diabetes
Glucose intolerance that begins during pregnancy, placenta produces hormones that help shift nutrients from mother to fetus and prevent low blood glucose of mother, placenta hormones resist insulin action and lead to increase in glucose levels, in attempt to decrease glucose levels, mother's body increases insulin by 3x, if pancreas can't produce enough insulin = GD
Risk factors for Gestational Diabetes
Glycosuria
Strong family history of type 2
Obesity
Prior history
Previous delivery of large infant
Screening for Gestational Diabetes: risk assessment at first visit, if increased risk - glucose testing, if lower risk - oral tolerance test at 24-28 weeks
Fetal Abnormalities in Gestational Diabetes
Macrosomia
Hypoglycemia
Hypocalcaemia
Polycythemia
Hyperbilirubinemia
Treatment of Gestational Diabetes
Close observation (maternal fasting and post meal monitoring, fetal growth measurements)
Diet alterations
Insulin therapy if diet not effective
50% of women with Gestational Diabetes develop Type 2 Diabetes in 5-10 years after delivery
Manifestations of Diabetes
Hyperglycemia
Polyphagia (excess hunger)
Polydipsia (excess thirst)
Polyuria (excess urination)
Rationale for Poly Symptoms
Lots of glucose that can't be moved into cells, glucose stays in blood and is excreted by kidneys, ineffective use of glucose leads to weight loss and increased appetite, increased blood glucose makes blood hypertonic that creates osmotic pressure that sucks water into vascular space, increased urination and thirst
General Clinical Manifestations of Diabetes
Weight loss
Blurred vision
Paresthesia (decreased sensation)
Fatigue/weakness
Chronic infections
Type 2 Diabetes Manifestations
Gradual onset, 90 years undetected, osmotic fluid/electrolyte loss from hyperglycemia, nonspecific symptoms (fatigue, recurrent infections, recurrent yeast infections, prolonged wound healing, vision changes, painful peripheral neuropathy on feet)
Diagnostics for Diabetes
Fasting plasma glucose
Casual blood glucose test
Oral glucose tolerance test
Capillary blood glucose monitoring
Glycosylated hemoglobin
The desired outcome of glycemic control in both type 1 and type 2 diabetes is normal blood glucose and preventing complications
Diabetes Management
Diet
Exercise
Antidiabetic agents (oral for type 2, injections for type 1 and advanced type 2)
Types of Insulin
Fast acting
Intermediate acting
Long acting
Acute Complications of Diabetes
Diabetic ketoacidosis
Hyperosmolar hyperglycemic state
Hypoglycemia
Diabetic Ketoacidosis
Characterized by hyperglycemia, ketosis, metabolic acidosis, primarily in type 1 but can occur in type 2 with severe stress, occurs with omission or inadequate use of insulin, lack of insulin leads to rapid breakdown of energy stores from muscle and fat, in ketosis, increased counter regulatory hormones are released leading to hyperglycemia
Diagnosis of Diabetic Ketoacidosis
Hyperglycemia (>13.8 mmol/L)
Decreased serum bicarbonate
Decreased arterial pH
Positive ketones (urine and blood)
Manifestations of Diabetic Ketoacidosis
Fruity breath odor
Increased heart rate
Hypotension and bradycardia
Increased rate and depth of respiration
Treatments for Diabetic Ketoacidosis
Improve circulatory volume and tissue perfusion (IV fluids)
Decrease blood glucose (insulin infusion)
Correct acidosis
Correct electrolyte imbalance (potassium in fluid)